KDM6B and diffuse large B-cell lymphoma: When DLBCL cells were treated with a small molecule KDM6 inhibitor (GSK-J4) not only was KDM6B expression inhibited, the cells were sensitized to chemotherapy agents (Mathur et al., 2017).